About the Authors
- Stéphane Pédeboscq
-
Affiliations INSERM U916 (VINCO), Institut Bergonié, Université Victor Segalen Bordeaux 2, Bordeaux, France, Service Pharmacie, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France
- Christophe Rey
-
Affiliation INSERM U916 (VINCO), Institut Bergonié, Université Victor Segalen Bordeaux 2, Bordeaux, France
- Muriel Petit
-
Affiliation Fluofarma, Pessac, France
- Catherine Harpey
-
Affiliation Institut de Recherche Servier, Suresnes, France
- Francesca De Giorgi
-
Affiliations INSERM U916 (VINCO), Institut Bergonié, Université Victor Segalen Bordeaux 2, Bordeaux, France, Fluofarma, Pessac, France
- François Ichas
-
Affiliations INSERM U916 (VINCO), Institut Bergonié, Université Victor Segalen Bordeaux 2, Bordeaux, France, Fluofarma, Pessac, France
- Lydia Lartigue
-
* E-mail: lartigue-faustin@bergonie.org
Affiliation INSERM U916 (VINCO), Institut Bergonié, Université Victor Segalen Bordeaux 2, Bordeaux, France
Competing Interests
The authors have read the journal’s policy and have the following conflicts: MP, FDG and FI work in a start-up company specialized in High Content Screening (Fluofarma); CH is employed by Servier Laboratories. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SP FDG FI LL. Performed the experiments: SP CR MP FDG. Analyzed the data: SP FDG FI LL. Contributed reagents/materials/analysis tools: CH FI. Wrote the paper: SP FDG FI LL.